Lack of Mucosal Cholinergic Innervation Is Associated With Increased Risk of Enterocolitis in Hirschsprung's Disease.


Journal

Cellular and molecular gastroenterology and hepatology
ISSN: 2352-345X
Titre abrégé: Cell Mol Gastroenterol Hepatol
Pays: United States
ID NLM: 101648302

Informations de publication

Date de publication:
2021
Historique:
received: 14 07 2020
revised: 09 03 2021
accepted: 09 03 2021
pubmed: 21 3 2021
medline: 28 1 2022
entrez: 20 3 2021
Statut: ppublish

Résumé

Hirschsprung's disease (HSCR) is a congenital intestinal motility disorder defined by the absence of enteric neuronal cells (ganglia) in the distal gut. The development of HSCR-associated enterocolitis remains a life-threatening complication. Absence of enteric ganglia implicates innervation of acetylcholine-secreting (cholinergic) nerve fibers. Cholinergic signals have been reported to control excessive inflammation, but the impact on HSCR-associated enterocolitis is unknown. We enrolled 44 HSCR patients in a prospective multicenter study and grouped them according to their degree of colonic mucosal acetylcholinesterase-positive innervation into low-fiber and high-fiber patient groups. The fiber phenotype was correlated with the tissue cytokine profile as well as immune cell frequencies using Luminex analysis and fluorescence-activated cell sorting analysis of colonic tissue and immune cells. Using confocal immunofluorescence microscopy, macrophages were identified in close proximity to nerve fibers and characterized by RNA-seq analysis. Microbial dysbiosis was analyzed in colonic tissue using 16S-rDNA gene sequencing. Finally, the fiber phenotype was correlated with postoperative enterocolitis manifestation. The presence of mucosal nerve fiber innervation correlated with reduced T-helper 17 cytokines and cell frequencies. In high-fiber tissue, macrophages co-localized with nerve fibers and expressed significantly less interleukin 23 than macrophages from low-fiber tissue. HSCR patients lacking mucosal nerve fibers showed microbial dysbiosis and had a higher incidence of postoperative enterocolitis. The mucosal fiber phenotype might serve as a prognostic marker for enterocolitis development in HSCR patients and may offer an approach to personalized patient care and new therapeutic options.

Sections du résumé

BACKGROUND & AIMS
Hirschsprung's disease (HSCR) is a congenital intestinal motility disorder defined by the absence of enteric neuronal cells (ganglia) in the distal gut. The development of HSCR-associated enterocolitis remains a life-threatening complication. Absence of enteric ganglia implicates innervation of acetylcholine-secreting (cholinergic) nerve fibers. Cholinergic signals have been reported to control excessive inflammation, but the impact on HSCR-associated enterocolitis is unknown.
METHODS
We enrolled 44 HSCR patients in a prospective multicenter study and grouped them according to their degree of colonic mucosal acetylcholinesterase-positive innervation into low-fiber and high-fiber patient groups. The fiber phenotype was correlated with the tissue cytokine profile as well as immune cell frequencies using Luminex analysis and fluorescence-activated cell sorting analysis of colonic tissue and immune cells. Using confocal immunofluorescence microscopy, macrophages were identified in close proximity to nerve fibers and characterized by RNA-seq analysis. Microbial dysbiosis was analyzed in colonic tissue using 16S-rDNA gene sequencing. Finally, the fiber phenotype was correlated with postoperative enterocolitis manifestation.
RESULTS
The presence of mucosal nerve fiber innervation correlated with reduced T-helper 17 cytokines and cell frequencies. In high-fiber tissue, macrophages co-localized with nerve fibers and expressed significantly less interleukin 23 than macrophages from low-fiber tissue. HSCR patients lacking mucosal nerve fibers showed microbial dysbiosis and had a higher incidence of postoperative enterocolitis.
CONCLUSIONS
The mucosal fiber phenotype might serve as a prognostic marker for enterocolitis development in HSCR patients and may offer an approach to personalized patient care and new therapeutic options.

Identifiants

pubmed: 33741501
pii: S2352-345X(21)00056-4
doi: 10.1016/j.jcmgh.2021.03.004
pmc: PMC8258990
pii:
doi:

Substances chimiques

Cytokines 0
Lipopolysaccharide Receptors 0
RNA, Messenger 0
Acetylcholinesterase EC 3.1.1.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

507-545

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Science. 2011 Oct 7;334(6052):98-101
pubmed: 21921156
Beitr Pathol. 1972;147(3):228-36
pubmed: 5086534
Gut. 1992 Jun;33(6):801-6
pubmed: 1624163
Proc Natl Acad Sci U S A. 2018 May 1;115(18):4696-4701
pubmed: 29666241
Trends Immunol. 2017 Dec;38(12):879-887
pubmed: 28844811
Nat Immunol. 2017 Jun;18(6):665-674
pubmed: 28459435
Immunity. 2011 Feb 25;34(2):237-46
pubmed: 21333554
Mol Med. 2019 Jan 7;25(1):1
pubmed: 30616543
Nat Immunol. 2020 Mar;21(3):343-353
pubmed: 32066951
Front Immunol. 2018 Oct 30;9:2407
pubmed: 30425709
J Comp Neurol. 1987 Mar 8;257(2):237-52
pubmed: 3571527
Cell. 2014 Aug 28;158(5):1210
pubmed: 28917294
J Pediatr Surg. 2009 May;44(5):933-8
pubmed: 19433173
Nat Med. 2016 Jan;22(1):72-7
pubmed: 26657141
Immunity. 2015 Sep 15;43(3):515-26
pubmed: 26377898
Gastroenterology. 1974 Feb;66(2):273-80
pubmed: 4810918
Gut. 2019 Aug;68(8):1406-1416
pubmed: 30472681
Lancet. 1982 Jan 9;1(8263):78-9
pubmed: 6119496
BMC Pediatr. 2020 Aug 24;20(1):399
pubmed: 32838761
Cell. 2016 Nov 3;167(4):1125-1136.e8
pubmed: 27814509
Pediatr Surg Int. 2013 Sep;29(9):873-81
pubmed: 23913261
Immunity. 2018 Dec 18;49(6):1191
pubmed: 30566884
J Pediatr Surg. 2014 Aug;49(8):1242-51
pubmed: 25092084
Gastroenterology. 2009 Sep;137(3):1029-39, 1039.e1-4
pubmed: 19427310
Genes (Basel). 2017 Dec 04;8(12):
pubmed: 29207565
Early Hum Dev. 2014 Dec;90(12):927-32
pubmed: 25448783
PLoS One. 2015 Apr 24;10(4):e0124172
pubmed: 25909773
Gastroenterology. 1953 Jun;24(2):173-85
pubmed: 13060549
Naunyn Schmiedebergs Arch Pharmacol. 1997 Apr;355(4):515-23
pubmed: 9109369
Front Neurosci. 2019 May 08;13:418
pubmed: 31133776
Nat Genet. 2008 Aug;40(8):955-62
pubmed: 18587394
J Immunol. 2020 Jan 15;204(2):271-279
pubmed: 31907269
Cell. 2018 Oct 4;175(2):400-415.e13
pubmed: 30173915
Nature. 2014 Jun 5;510(7503):157-61
pubmed: 24759321
Innate Immun. 2017 Aug;23(6):557-565
pubmed: 28770666
J Pathol Bacteriol. 1961 Oct;82:363-6
pubmed: 14479676
Cell. 2016 Jan 28;164(3):378-91
pubmed: 26777404
Curr Opin Immunol. 2019 Feb;56:94-99
pubmed: 30530300
World J Gastroenterol. 2011 Jun 14;17(22):2740-7
pubmed: 21734782
J Clin Invest. 2011 Dec;121(12):4787-95
pubmed: 22045567
Nature. 2017 Sep 14;549(7671):277-281
pubmed: 28869974
Proc R Soc Med. 1967 Aug;60(8):803
pubmed: 6035410
Nature. 2016 Jul 21;535(7612):440-443
pubmed: 27409807
Pathologe. 2007 Mar;28(2):105-12
pubmed: 17294154
Immunity. 2017 Apr 18;46(4):532-548
pubmed: 28423335
Microbiome. 2016 Mar 14;4:12
pubmed: 26975510
Allergy. 2019 Sep;74(9):1748-1759
pubmed: 30897213
Mol Med. 2016 Oct;22:464-476
pubmed: 27341335
Gut. 2014 Jun;63(6):938-48
pubmed: 23929694
Nature. 2020 Jul;583(7816):441-446
pubmed: 32641826
J Pediatr Surg. 2003 Mar;38(3):417-21; discussion 417-21
pubmed: 12632359
Nature. 2008 Oct 9;455(7214):808-12
pubmed: 18716618
Cell Host Microbe. 2019 May 8;25(5):756-765.e5
pubmed: 31003940
Neurogastroenterol Motil. 2020 Oct;32(10):e13911
pubmed: 32515156
Front Cell Dev Biol. 2020 Jul 07;8:606
pubmed: 32733896
Front Immunol. 2015 Dec 07;6:613
pubmed: 26697009
J Pediatr Surg. 1972 Feb;7(1):11-7
pubmed: 5013118
Nature. 2020 Sep;585(7826):591-596
pubmed: 32526765
Arch Dis Child. 1969 Jun;44(235):406-17
pubmed: 5785192
Prz Gastroenterol. 2014;9(5):264-9
pubmed: 25395999
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14852-7
pubmed: 25267612
Gastroenterology. 2006 Oct;131(4):1122-30
pubmed: 17030182
Nature. 2013 Sep 5;501(7465):52-7
pubmed: 23965627
Neurogastroenterol Motil. 2016 Jun;28(6):948-53
pubmed: 26920654
Nature. 2017 Sep 14;549(7671):282-286
pubmed: 28869965
Inflammation. 2019 Feb;42(1):319-330
pubmed: 30259241
Sci Immunol. 2018 Mar 16;3(21):
pubmed: 29549139
Nature. 2000 May 25;405(6785):458-62
pubmed: 10839541
Cell Immunol. 2018 Aug;330:142-150
pubmed: 29291892

Auteurs

Simone Keck (S)

Department of Pediatric Surgery, University Children's Hospital Basel (UKBB) and University of Basel, Basel, Switzerland. Electronic address: simone.keck@unibas.ch.

Virginie Galati-Fournier (V)

Department of Pediatric Surgery, University Children's Hospital Basel (UKBB) and University of Basel, Basel, Switzerland.

Urs Kym (U)

Department of Pediatric Surgery, University Children's Hospital Basel (UKBB) and University of Basel, Basel, Switzerland.

Michèle Moesch (M)

Department of Pediatric Surgery, University Children's Hospital Basel (UKBB) and University of Basel, Basel, Switzerland.

Jakob Usemann (J)

Department of Pediatric Pulmonology, University Children's Hospital Basel (UKBB), Basel, and Division of Respiratory Medicine, University Children's Hospital Zurich, Zurich, Switzerland.

Isabelle Müller (I)

Department of Pediatric Surgery, University Children's Hospital Basel (UKBB) and University of Basel, Basel, Switzerland.

Ulrike Subotic (U)

Department of Pediatric Surgery, University Children's Hospital Basel (UKBB) and University of Basel, Basel, Switzerland; Department of Pediatric Surgery, University Children's Hospital Zurich, Zurich, Switzerland.

Sasha J Tharakan (SJ)

Department of Pediatric Surgery, University Children's Hospital Zurich, Zurich, Switzerland.

Thomas Krebs (T)

Department of Pediatric Surgery, Children's Hospital of Eastern Switzerland, St Gallen, Switzerland.

Eleuthere Stathopoulos (E)

Department of Pediatric Surgery, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.

Peter Schmittenbecher (P)

Department of Pediatric Surgery, Municipal Hospital, Karlsruhe, Germany.

Dietmar Cholewa (D)

Department of Pediatric Surgery, University Hospital of Bern, Bern, Switzerland.

Philipp Romero (P)

Department of Pediatric Surgery, University Hospital of Heidelberg, Heidelberg, Germany.

Bertram Reingruber (B)

Department of Pediatric Surgery, Florence Nightingale Hospital, Düsseldorf, Germany.

Elisabeth Bruder (E)

Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.

Nig Study Group (NS)

NIG Study Group, Lausanne, Switzerland; Department of Pathology, University Hospital of Lausanne (CHUV) and University of Lausanne, Lausanne, Switzerland.

Stefan Holland-Cunz (S)

Department of Pediatric Surgery, University Children's Hospital Basel (UKBB) and University of Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH